{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:04:34Z","timestamp":1763661874268},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":12,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Daiichi Sankyo, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1002\/jcph.567","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T22:08:13Z","timestamp":1434146893000},"page":"67-77","source":"Crossref","is-referenced-by-count":16,"title":["Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain"],"prefix":"10.1002","volume":"56","author":[{"given":"Matthew M.","family":"Hutmacher","sequence":"first","affiliation":[{"name":"Ann Arbor Pharmacometrics Group; Ann Arbor MI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Frame","sequence":"additional","affiliation":[{"name":"Wolverine Pharmacometrics Corporation; Ann Arbor MI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Miller","sequence":"additional","affiliation":[{"name":"Translational Medicine & Clinical Pharmacology; Daiichi Sankyo, Inc.; Edison NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Truitt","sequence":"additional","affiliation":[{"name":"Translational Medicine & Clinical Pharmacology; Daiichi Sankyo, Inc.; Edison NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Merante","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Development Ltd.; Chiltern Place, Chalfont Park Buckinghamshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"issue":"12","key":"10.1002\/jcph.567-BIB0001|jcph567-cit-0001","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2337\/dc14-1044","article-title":"DS5565-A-U201 US Phase II Study Investigators. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study","volume":"37","author":"Vinik","year":"2014","journal-title":"Diabetes Care."},{"issue":"9","key":"10.1002\/jcph.567-BIB0002|jcph567-cit-0002","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/sim.4155","article-title":"Estimating transformations for repeated measures modeling of continuous bounded outcome data","volume":"30","author":"Hutmacher","year":"2011","journal-title":"Stat Med."},{"key":"10.1002\/jcph.567-BIB0003|jcph567-cit-0003","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-2873-3","volume-title":"Transformation and Weighting in Regression","author":"Carroll","year":"1988"},{"issue":"2","key":"10.1002\/jcph.567-BIB0004|jcph567-cit-0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/pst.432","article-title":"Fitting Emax models to clinical trial dose-response data","volume":"10","author":"Kirby","year":"2011","journal-title":"Pharm Stat."},{"issue":"5","key":"10.1002\/jcph.567-BIB0005|jcph567-cit-0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/B:JOPA.0000008157.26321.3c","article-title":"A two-part mixture model for longitudinal adverse event severity data","volume":"30","author":"Kowalski","year":"2003","journal-title":"J Pharmacokinet Pharmacodyn."},{"issue":"6","key":"10.1002\/jcph.567-BIB0006|jcph567-cit-0006","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10928-009-9137-5","article-title":"Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder","volume":"36","author":"Frame","year":"2009","journal-title":"J Pharmacokinet Pharmacodyn."},{"issue":"440","key":"10.1002\/jcph.567-BIB0007|jcph567-cit-0007","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/01621459.1997.10473642","article-title":"Analysis of nonrandomly censored ordered categorical longitudinal data from analgesic trials","volume":"92","author":"Sheiner","year":"1997","journal-title":"J Am Stat Assoc."},{"issue":"3","key":"10.1002\/jcph.567-BIB0008|jcph567-cit-0008","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1011579109640","article-title":"Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test","volume":"28","author":"Kowalski","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn."},{"issue":"7","key":"10.1002\/jcph.567-BIB0009|jcph567-cit-0009","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care."},{"issue":"3","key":"10.1002\/jcph.567-BIB0010|jcph567-cit-0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain."},{"issue":"11","key":"10.1002\/jcph.567-BIB0011|jcph567-cit-0011","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology."},{"key":"10.1002\/jcph.567-BIB0012|jcph567-cit-0012","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-9-6","article-title":"Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain","volume":"9","author":"Quilici","year":"2009","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1002\/jcph.567-BIB0013|jcph567-cit-0013","first-page":"1","article-title":"Developing new molecules for the treatment of painful diabetic peripheral neuropathy: is it feasible given the magnitude of the placebo response in proof of concept clinical studies?","volume":"4","author":"Merante","year":"2013","journal-title":"J Diabetes Metab."},{"issue":"1)","key":"10.1002\/jcph.567-BIB0014|jcph567-cit-0014","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.clpt.6100491","article-title":"Exposure-response analysis for spontaneously reported dizziness in pregabalin-treated patient with generalized anxiety disorder","volume":"84","author":"Ito","year":"2008","journal-title":"Clin Pharmacol Ther."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.567","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.567\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:03:08Z","timestamp":1657803788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.567"}},"subtitle":["Exposure-Response Modeling of Average Daily"],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.567","archive":["Portico"],"relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,20]]}}}